.0011 by lunch? Imagine how this trades with news IMMEDIATELY after the holidays??
ELTZ$$

We will be banking it very soon. Huge contracts here. New customers to be revealed immediately after the holidays!

It certainly is day to day!
#MJCONGLOMERATE
#SHOCKCOMING

Clinically proven Gold Standard. Can't beat it imo!
#MJCONGLOMERATE

We also have to remember that former CEO Brian Conway walked away with 66 million shares but he can't sell for another 6 months. Why would he take that deal unless he knew that in 6 months time this ticker would be trading in copper or more likely silver? He knows this is a 350 million pound gorilla that is about to go ape s--t. For all his mistakes and F ups over the last couple of years I believe he got us the best deal ever and there is nothing but upside with these revs!
LIBE$$

I believe we are sitting on a goldmine! Anybody who reads the filings without bias and understands the amazing R&D and contracts that we have in korea will realize that this is a very rare opportunity. We say goodbye to the trips next week. .0056+++ very soon imho!

Can't lose from down here, this is only going up. Easy 10 bagger for all that comprehend the latest 8K imo!

Holding for 005. Easy money! Well played by new CEO!
LIBE$$

In Chattanooga! Lol!

Thanks for sharing. PR could be at any moment. I sure would like an AH PR mentioning the mega rev Hyundai contract. That will attract the attention of the market. Despite the super 8K having mentioned it I believe a PR with a great headline mentioning Hyundai will get us running imo!
LIBE$$

Great find Magnum. Seen this before but glad you shared for the many newbies here. Since Hyundai owns Kia and most Kia parts are really Hyundai parts I wonder if Kia vehicles have our muffler tech too?
LIBE$$

Great buying. Will be worth it. Wait for major PR with Hyundai contract imo! This will fly!
LIBE$$

Huge bid growing. Showing strength!
LIBE$$

I think shorts gonna need some of Bob's special wet wipes when they realize that this is a 350 million pound gorilla in a 0005+ cage!
Revs are everything. So much upside imho!
LIBE$$

You called it from day one Magnum. This is still a no brainer. I did sell my 0001's yesterday but I had to reload at 0006 today and will continue to load more tomorrow.
LIBE$$

Liberated Energy
@LIBEnergy
Keep in mind that this is not for NGEN. This was the handle that was used by FORMER CEO!
LIBE$$

I see it too. Brian did exactly what he said he would do. Success is the best revenge!
#LIBE

I actually did. Been in this ticker for quite some time and it's nice to see some excitement for once!
#HYUNDAI/SAMSUNG
#THISIS4REAL

The 8K is a pretty interesting read:

https://www.sec.gov/Archives/edgar/data/1503161/000149315219014188/form8-k.htm

I had to come out of exile to thank you for the awesome DD Magnum. I usually just skip to your posts and now I remember why! Glad I slapped the ask today to add to my collection. I was just about 3/4 of the volume! Another 3 tomorrow and I'll be at 20. Worth the risk with Conway out of the picture. Back to my hideout.

Just 4 months ago Doc stated:

And then at IFAH he discusses "OUR" Company in ISRAEL!
In May Euromed Therapeutics (formerly Rewardstream) Releases a PR naming Dr Dalton as Director of the company. We already knew we had clinical trials done in Israel under the auspices of Dr Mechoulam"s team at Hebrew University in Jerusalem and today we see this:
https://euromedtherapeutics.com/

I also like seeing Dr Dalton being mentioned in the following article. EuroMed Therapeutics has several board members and directors plus a CEO yet they opted to mention Dr Dalton in their latest article. Plus the fact that Doc calls them OUR COMPANY IN ISRAEL while speaking at IFAH stands out to me as he was speaking about EuroMed from a Univec Conglomerate perspective. Even the blind can see where this is headed.

First, Last and Always: Cannabis Innovation Never Ends in Israel -- CFN Media

Published: July 25, 2019 8:03 a.m. ET


Seattle, Washington--(Newsfile Corp. - July 25, 2019) - CFN Media Group ("CFN Media" , the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing EuroMed Therapeutics.

When the word "cannabis" is heard, "Israel" probably isn't one of the first things that jumps to mind. But, for investors it should be. For that matter, so should EuroMed Therapeutics, an upstart heading toward the public domain. Here's why.

Top Notch R&D, Perfect Weather and Locale

First, simply consider the overall startup picture and the fact that the tiny country of about 8 million people has become globally recognized as a tech innovation hub, startup nation and accelerator. OurCrowd founder and CEO Jon Medved estimated that $6.5 billion went into Israeli startups in 2018 when telling Bloomberg to expect more Israeli unicorns coming down the pipeline.

Now consider Israel's pioneering place in the cannabis space. In the 1960's, the Godfather of cannabis medicine, Dr. Raphael Mechoulam, was the first to isolate, analyze and synthesize cannabinoids in cannabis. Dr. Mechoulam began his lifetime of cannabis work at Israel's Weizmann Institute before moving on to the Hebrew University of Jerusalem.


Israel became only the third country in the world to allow cannabis exports


The country simply has a long lineage of superior R&D in the cannabis sector, research that for years has enjoyed financial support from the U.S. National Institute of Health. Decades of research further lends to expertise in medical and agricultural technology, comprehensive infrastructure, regulations and plenty of skilled labor. In fact, Max Stern Yezreel Valley College outside of Nazareth will soon be offering a degree in medical cannabis.


On that point, innovation never ends in the country. In a recent study, Israeli researchers discovered that medical cannabis therapy improved pain intensity and symptom of fibromyalgia, one of the most common and misunderstood chronic pain conditions in the world.

With the passage of legislation earlier this year, Israel became only the third country in the world (along with Canada and the Netherlands) to allow cannabis exports. Cannabis exports are forecast to reach between $1 billion and $4 billion in the next decade.

On a per capita basis, Israel is a top cannabis consumer, with nearly 30% of the country trying marijuana in 2017. Currently, there are about 30,000 medical marijuana patients consuming about 14 tons of cannabis annually, numbers that are expected to soon rise to 120,000-170,000 patients and 60-90 tons of cannabis.

The climate is ideal for four harvests during year-round cannabis cultivation in low-cost greenhouses. Furthermore, the country is ideally located to send its cannabis exports any direction, including the burgeoning European cannabis markets that are expected to reach $66 billion in the next decade as more and more countries exit the days of prohibition.

Unique Opportunity with EuroMed

EuroMed, who is joining the public markets through a reverse merger with RewardStream Solutions Inc., is a holder of one of only nine cultivation licenses for export in Israel. It bears repeating that EuroMed has a maximum of eight competitors as things currently stand. Compare that to Canada (likely a country that springs to mind upon hearing the word cannabis), which has issued about 165 licenses.


EuroMed is a ground floor opportunity. Literally. Working with the greenhouse engineering and construction experts at Eisenberg Agri Company (Israel) Limited, the company is laying down the foundation for a 100,000 square foot, modular-design greenhouse located 45 minutes outside of Jerusalem, with expectations for completion during the fourth quarter. Phase 1 of construction includes 22,000 square feet of operational greenhouse by the end of Q1 2020 with the cultivation process launched during Q2.

The state-of-the-art design of the greenhouse will allow for the addition of 11,000 square feet greenhouse every 30 days. Other benefits include the greenhouse being fully customizable to achieve the ideal micro-climate, which yields up to 20% higher output.

As for costs, start-up expenses are shaved in half compared to conventional greenhouses, after which operating costs are expected to be only about 5% of typical buildings.

Low Cost = Big Margin

Add these factors up and the sum is a premium cannabis product produced at approximately just $0.30 cents per gram. EuroMed says it will leverage domestic distribution agreements for Israel and that it also plans to export product to Europe, where retail prices range as high as $18 per gram. The company is already in discussions for off-take and joint venture distribution partners to further accelerate penetrating the European markets.

Management expects to harvest 5,500 kilograms of medicinal grade cannabis in the first 12 months of operations, which will translate to $22.0 million based on conservative pricing of $4 per gram.

EuroMed isn't flying blind here. The lean, but highly seasoned team, which includes Dr. David Dalton, former EVP of Rite Aid and current director of Pennsylvania-licensed cannabis producer and processor AGRiMED, as a director, has some good comps to base their projections upon. For instance, fellow Israeli cannabis company InterCure is able to produce 10,000 kilograms annually on their 54,450 square foot property.

The Israeli-benefit abounds on this front too when considering that Canadian greenhouse cannabis cultivator Tantalus Labs is able to produce only 10,000 kilograms annually from its 120,000 square foot facility.

Lab Too

The company also intends to have an extraction lab to cater to an extracts market expected to be worth $130 billion globally by 2029. There are many benefits to this type of vertical integration, including better yields by using every part of the plant and increasing shelf life without fear of loss of raw material. Canada is trying to iron out laws about edibles, as are other parts of the world, making this a market segment than cannot be overlooked, albeit for pharmaceuticals or an additive for an infused sports drink.

To keep developments moving along, EuroMed is looking to raise between $2.5 million and $5.0 million via subscription receipts, with the largest portion of the raise being earmarked for completion of the greenhouse, which will set the company on its way towards it domestic and international supply targets.

Euromed Therapeutics Website up and running!
https://euromedtherapeutics.com/

And that is all fact Jack! Wait until the other pieces are revealed
UNVC$$

Shock and awe coming. Perhaps one day the blind shall see? But probably not!
#MJCONGLOMERATE
#REALDDAVAILABLEELSEWHERE

We deal with HRVSF, NOT Harvest One. False info. AGAIN!

$185 Million revs last year, closer to $200 million in 2019 no doubt. One piece of the Conglomerate puzzle!

I tested it several times today. What are they hiding?

Everything is good. More than good from what I know. Nothing is broken or stuck. You will all soon see. Prepare to be shocked. I will post many old posts from last year as each bit of news comes out to show how on the money me and the guys in the Circle were. And by the way, I never left, I just prefer to be somewhere with like minded investors.
#MJCONGLOMERATE
#BETA
#EXPECTTHEUNEXCPECTED

It is huge and the scope of it will SHOCK MANY when all comes out VERY SHORTLY!

This will not fail. All is done and in place. The Set Go is day to day at this point. IFAH should be a fascinating platform for Doc to speak even more freely about this life changing Conglomerate!
#MJCONGLOMERATE
#BIGPHARMA
#PRESCRIPTIONCANNABIS

Correct! HRI $185 Million. Wellness teladoc, PPSI, Wellness RX all together worth more than HRI and ALL rolling up into Univec Conglomerate Inc. This is not counting SEVERAL PRESCRIPTION MEDS as I have been SCREAMING for close to a year!
Note Date, I have dozens! Follow the DD trail!

What OTC CEO can bring a former Merck VP onto the board?
Close a deal with Harvest?
Sign a deal with Rite Aid where he himself was once VP?
Sign a deal with Walmart?
Distribute meds at 70K+ pharmacies?
Take control of a company with a grow license in Israel?
Have several meds receive Gold Standard after clinical trials (Israel)?
Own a $185 Million dollar private company (HRI) that IS rolling up into the conglomerate?

I can continue for pages but I believe that everyone, despite motive, is as clear as day on these FACTS!

#MJCONGLOMERATE

We found it within an hour of the hint. Pretty easy, I would highly recommend that if anybody wants to understand what is about to happen with the Conglomerate and comprehend just how much of a life changing investment this is that they seriously put some effort into connecting the dots. It will be worth it$$
#MJCONGLOMERATE
#BIGPHARMA
#WORLDWIDEDISTRIBUTION

We have an advantage from our vantage point
See you in the winners circle.
#GOLDSTANDARD
#BETA
#DOCWILLSHOCK

DD disabled (nobody on this board of course) are great at dumping and then living in regret soon after! imo!
Still surprised nobody on this board solved the riddle of Ben Carson and this one. Smh: